Stockreport

Travere Therapeutics to Report First Quarter 2024 Financial Results

Travere Therapeutics, Inc.  (TVTX) 
PDF SAN DIEGO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report first quarter 2024 financial results on [Read more]